Problems and Pitfalls in the Isolation of an Endogenous Na+, K+-ATPase Inhibitor.

Hypertension - United States
doi 10.1161/01.hyp.10.5_pt_2.i57
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)